Integration of endovascular therapy of ruptured abdominal and iliac aneurysms in the treatment algorithm: a single-center experience in a medium-volume vascular center
Language English Country United States Media print-electronic
Document type Comparative Study, Evaluation Study, Journal Article
PubMed
25082435
DOI
10.1177/1538574414544383
PII: 1538574414544383
Knihovny.cz E-resources
- Keywords
- abdominal aortic aneurysm, endovascular treatment, iliac artery aneurysm, rupture, stent-graft,
- MeSH
- Algorithms * MeSH
- Aortic Aneurysm, Abdominal diagnosis mortality surgery MeSH
- Iliac Aneurysm diagnosis mortality surgery MeSH
- Aortography methods MeSH
- Time Factors MeSH
- Blood Vessel Prosthesis MeSH
- Blood Vessel Prosthesis Implantation * adverse effects instrumentation mortality MeSH
- Endovascular Procedures * adverse effects instrumentation mortality MeSH
- Delivery of Health Care, Integrated * MeSH
- Critical Pathways MeSH
- Middle Aged MeSH
- Humans MeSH
- Hospitals, University * MeSH
- Tomography, X-Ray Computed MeSH
- Aneurysm, Ruptured diagnosis mortality surgery MeSH
- Retrospective Studies MeSH
- Risk Factors MeSH
- Aortic Rupture diagnosis mortality surgery MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Stents MeSH
- Feasibility Studies MeSH
- Treatment Outcome MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Evaluation Study MeSH
- Comparative Study MeSH
- Geographicals
- Czech Republic MeSH
PURPOSE: To evaluate the influence of endovascular therapy of ruptured abdominal or iliac aneurysms on total mortality. MATERIALS AND METHODS: We analyzed the mortality of 40 patients from 2005 to 2009, when only surgical treatment was available. These results were compared with the period 2010 to 2013, when endovascular aneurysm repair (EVAR) was assessed as the first option in selected patients. RESULTS: During 2005 to 2009, the mortality was 37.5%. From 2010 to 2013, 45 patients were treated with mortality 28.9%. Open repair was performed in 35 (77.8%) patients and EVAR in 10 (22.2%) patients. The 30-day and 1-year mortality rates of the EVAR group were 0% and 20%, respectively, and the total mortality rate was 30% during follow-up (median 11 months, range 1-42 months). The 30-day mortality in the surgical group remained unchanged, at 37.1%, and 1-year and total mortality rates were 45.7% and 51.4%, respectively. CONCLUSION: Following integration in the treatment algorithm, EVAR decreased total mortality in our center by 8.6%.
References provided by Crossref.org
